Jiachang Gong,Lisa J. Christopher,Vinod Kumar Arora
申请号:
US13500365
公开号:
US20120196814A1
申请日:
2010.10.04
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention is directed to metabolites of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol, the compound of formula (I), pharmaceutical compositions thereof, and to methods of using the metabolites and the pharmaceutical compositions in the treatment of cancer.